Our blog about Bremelanotide reviews the pros and cons of this new drug, which has been trialed on patients with low libido. The correct dosage for pt 141 was monitored, and here are some of the results of what was discovered.
The story so far is the FDA (The Food and Drug Administration) had approved bremelanotide to treat premenopausal women with hypoactive sexual desire disorder. In the study of 1,200 women, those who used the bremelanotide dosage injected it under the skin of the abdomen or in the thigh at least 45 minutes before sexual activity, had better sexual desire scores compared to placebo patients (25% vs. 17 %). The FDA notes that patients should not use more than one dose per day or eight doses per month. They should stop treatment at 8 weeks if they do not notice any improvement in sexual desire and distress. For more information read this link:https://en.wikipedia.org/wiki/Bremelanotide
Bremelanotide Reviews and Side Effects
Approximately 40% of patients in the studies experienced nausea, often after the first injection. About 1% experienced darkening of the gums and skin (bremelanotide activates melanocortin receptors that are widely expressed in the brain). The drug is also associated with an increase in blood pressure that usually goes within 12 hours, so it should not be used in patients with uncontrolled hypertension or cardiovascular disease. It is also contraindicated in patients taking oral naltrexone for opioid or alcohol use disorder.
It is estimated that 8% to 10% of women have DSH – one of the sexual disorders that most affect the female population. They also warn that the problem has a high impact on women’s self-esteem and confidence, as well as interfering with the relationship and undermining their body image. Therefore, the existence of a less restrictive drug capable of stimulating libido is extremely important for these women.
Vyleesi Bremelanotide Explained
The peptide Bremelanotide is sold under the name Vyleesi and is a treatment to help low libido in women that can occur from illness, or before menopause. Vyleesi acts on the central nervous system to improve levels of dopamine the hormone responsible for arousal.
According to the experts, Vyleesi showed an improvement in women’s desired feelings and decreased feelings of anguish about sex. There was no significant interference in sexual satisfaction rates. This points to the possibility that low libido is not the only factor affecting female sexuality only part of the treatment. Although effective in treating low sex drive in women. Experts say the new drug will not necessarily be a first-line treatment for the condition.
So, it is advisable to seek other therapies first. There are many points to consider first before prescribing medication. Health professionals should check other possible causes for low libidos, such as underlying medical conditions, side effects due to medications or stress within the relationship.
We hope the facts in this blog Bremelanotide reviews have helped. If you are in the research industry and searching for pt-141 for sale USA check out Peptides USA.